Results 31 to 40 of about 35,852 (230)
Adiponectin as a novel biomarker of disease severity in alopecia areata
Scientific Reports, 2021 The frequent coexistence of obesity and metabolic syndrome in patients with alopecia areata may indicate the common pathogenetic pathway in these conditions with an important role of adipokines.
Anna Stochmal +6 more
doaj +1 more source
, 2015 Alopecia areata (AA) is a common, non-scarring alopecia that usually presents as well-circumscribed patches of sudden hair loss and affects 0.1-0.2% of the population. The aetiology of AA is thought to be both genetic and autoimmune in nature. One hundred and thirty-nine single nucleotide polymorphisms linked to AA have been identified in 8 regions of ...
Eshini Perera +2 more
openaire +3 more sources
Alopecia areata incognita [PDF]
Journal of the American Academy of Dermatology, 2011 Alopecia areata incognita, also known as diffuse alopeciaareata, is a rare form of alopecia areata described pre-dominantly in young women. In cases of alopecia areataincognita, the typical patchy distribution of hair loss inclassical alopecia areata is absent, but abrupt and intensehair loss is characteristic.
Molina, Luciana +3 more
openaire +6 more sources
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Cognitive-behavioural psychotherapy and alopecia areata
, 2017 Alopecia areata (also known as spot baldness) is a disease with multifactorial aetiology, including genetic, hormonal, autoimmune and psychological factors as well as nervous system disorders.
Marta Kuty-Pachecka
core +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several
Jundong Huang +5 more
doaj +1 more source
Acta Dermato-Venereologica, 2018 The development of androgenetic alopecia is associated with a risk of developing cardiovascular diseases, but the association of alopecia areata with cardiovascular diseases in humans is largely unexplored.
Eddy Hsi Wang +7 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 Alopecia areata is a non-scarring, autoimmune hair loss disorder that is associated with inflammatory bowel disease. Alopecia areata and inflammatory bowel disease may have a common pathogenic mechanism that involves the Janus kinase/STAT pathway.
Leah A Johnston +2 more
doaj +1 more source
Navigating the Complexities of Alopecia Areata: A Comprehensive Analysis [PDF]
, 2023 One prevalent type of body and head hair loss that doesn\u27t leave scars is called alopecia areata (AA). In this Review, we studied the Pathogenesis of Alopecia Areata, Epidemiology, Cells implicated in alopecia areata immune reactions, Immunology ...
Anshu +5 more
core +2 more sources
Allergology International, 2020 Background: The Japanese guidelines for the treatment of alopecia areata list topical immunotherapies as a drug therapy for this condition. However, there is insufficient evidence of its efficacy to support this recommendation. Thus, we sought to clarify
Keisuke Sakai +6 more
doaj +1 more source